Cargando…
Securin promotes the identification of favourable outcome in invasive breast cancer
BACKGROUND: Securin is a recently recognised oncogene with multiple known functions in initiation, progression and cell cycle regulation in several malignant diseases, including breast carcinoma. METHODS: In this paper, the prognostic value of securin is evaluated by immunohistochemistry in 310 pati...
Autores principales: | Talvinen, K, Karra, H, Hurme, S, Nykänen, M, Nieminen, A, Anttinen, J, Kuopio, T, Kronqvist, P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743366/ https://www.ncbi.nlm.nih.gov/pubmed/19690544 http://dx.doi.org/10.1038/sj.bjc.6605237 |
Ejemplares similares
-
Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer
por: Talvinen, K, et al.
Publicado: (2008) -
Cdc20 and securin overexpression predict short-term breast cancer survival
por: Karra, H, et al.
Publicado: (2014) -
Separase is a marker for prognosis and mitotic activity in breast cancer
por: Gurvits, Natalia, et al.
Publicado: (2017) -
Predicting aggressive outcome in T1N0M0 breast cancer
por: Kronqvist, P, et al.
Publicado: (2004) -
Securin (hPTTG1) expression is regulated by β-catenin/TCF in human colorectal carcinoma
por: Hlubek, F, et al.
Publicado: (2006)